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Abstract 
Purpose: To isolate and evaluate α-glucosidase inhibitors from dichloromethane extract of Croton 
bonplandianum Baill as probable remedy for management of diabetes. 
Methods: Activity-guided isolation of constituents from dichloromethane extract was carried out. 
Fractionation of dichloromethane extract by  column chromatography on silica gel and Sephadex LH 20 
using different mobile phase systems led to the isolation of compounds (A-I). The structures of these 
isolated compounds were established by ultraviolet (UV) and infrared (IR) spectroscopy. Proton nuclear 
magnetic resonance (1H NMR), 13C NMR and mass spectrophotometry, electron impact mass 
spectroscopy (EIMS) and high resolution mass spectroscopy (HRMS) were used for structural 
elucidation. All the isolated compounds were screened for their α-glucosidase inhibitory activity using 
standard in vitro α-glucosidase inhibition assay. Acarbose was used as positive control.  
Results: On the basis of their physical and spectral data from literature, the isolated compounds were 
identified as  n-pentacosanyl-n-nonadeca-7′-en-9′-α-ol-1′-oate (A), n-tridecanyl n-octadec-9,12-dienoate 
(B), nonacosyl hexadecanoate (C), heptacosanoic acid (D), 1,3,5-trihydroxy-2-hexadecanoylamino-
(6e,9e)-heptacosdiene (E),cumarin (F), betulin (G), stigmasterol (H), and 3,5-dimethoxy 4-hydroxy 
cinnamic  acid (I).Compounds F, GandI possessed significant α-glucosidase inhibitory activity in a 
concentration-dependent manner with 50 % inhibitory concentration (IC50) values ranging from 23.0 to 
26.7 μg/mL, relative to that of the positive control, acarbose (IC50, 38.2 µg/mL). 
Conclusion: The plant contains bioactive compounds with α-glucosidase inhibitory activity. This 
lendssome support for the traditional use of this herb in the management of diabetes. Compound F, 
GandI possessed significant α-glucosidase inhibitory activity in a concentration-dependent manner and 
may be developed as a new α-glucosidase inhibitor. 
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Croton bonplandianum Baill (Euphorbiaceae) is a 
monoecious woody shrub, which is 1 - 5 meter 
high with whorled branches. The plant grows in 
sandy clay soil along roadsides, irrigation canal 
banks, in plantations and on waste ground [1]. It 
has been reported that this plant grows in South 
Balivia, Paraguay, South West Brazil, North 
Argentina, Bangladesh, South America, South 
India and Pakistan [2]. In Pakistan, this plant is 
found near Khyber, Attock, Wah, Rawalpindi, 
Sargodha, Gujarat, Sialkot, Lahore and Karachi. 
Among the medicinal benefits of plants, 
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antioxidant properties have received increasing 
attention due to their role in preventing or down-
regulating myriads of oxidative damages caused 
by free radicals in the body [3]. Oxidative stress 
is initiated by free radicals, which seek stability 
through electron pairing with biological 
macromolecules such as proteins, lipids and 
DNA in healthy human cells and cause protein 
and DNA damage along with lipid peroxidation. 
These changes contribute to cancer, 
atherosclerosis, cardiovascular diseases, ageing 
and inflammatory diseases [4]. Preliminary 
screening study revealed that the 
dichloromethane extract of Croton 
bonplandianum exhibited significant α-
Glucosidase inhibition activity of 97.89 % with 50 
% inhibitory concentration (IC50) of 14.93 mg/ml 
while acarbose (reference) exhibited 92.23 % 
inhibition with IC50 of 38.25 mg/ml [5]. Therefore, 
further phytochemical investigation of Croton 
bonplandianum is necessary to ascertain its 
suitability as a medicinal food for postprandial 




Plant material  
 
The plant material was collected from Sargodha 
District, Pakistan. The plant was identified as 
Croton bonplandianum by Professor Dr Altaf 
Ahmad Dasti taxonomist, Institute of Pure and 
Applied Biology, Bahauddin Zakariya University, 
Multan and a voucher specimen (no. SWT-446) 
was deposited at the herbarium of Institute of 
Pure and Applied Biology, Bahauddin Zakariya 
University, Multan, Pakistan.  
 
Chemicals, reagents and instrumentation 
 
α-Glucosidase (EC 3.2.1.20) from 
Saccharomyces cerevisiae (750 UN), p-
nitrophenyl- α-D-glucopyranoside and dimethyl 
disulfide (DMDS) were obtained from Sigma 
Chemical Co. (St. Louis, MO, USA). Acarbose 
and DMSO were purchased from Merck 
(Darmstadt, Germany).All the solvents used for 
extraction and isolation like methanol, 
dichloromethane, chloroform, n-hexane, ethyl 
acetate, ethanol, proponol, n-butanol Vanillin, 
silica gel (70-230 mesh) and TLC aluminium 
sheets 20 x 20 cm, Silica gel 60 F254. , were 
imported from Merck KgaA Darmstadt Germany. 
Ultraviolet (UV) spectra were recorded in 
chloroform on a Shimadzu UV 240 (Shimadzu 
Corporation, Kyoto, Japan) and Perkin-Elmer 
spectrophotometers. Infrared (IR) JASCO A-302 
(Japan Spectroscopic Co. Limited) 
spectrophotometers. Proton magnetic resonance 
(1H-NMR) spectra were recorded either in CDCl3, 
400 MHz on Bruker AM-300, AM-400 and AMX-
500 nuclear magnetic resonance spectrometers 
respectively. Mass spectra were recorded on 
Finnigan MAT 312 double focusing mass 
spectrophotometer (Thermo Finnigan, Germany) 
both connected to PC 386 computer system or 
Peak matching, field desorption (FD) 
measurements performed on the MAT 312 mass 
spectrophotometer (Thermo Finnigan, Germany). 
High resolution mass Spectroscopy (HRMS) 
spectra were recorded on JEOL JMS HX 110 
mass spectrophotometer (Blue Lion Biotech, 
Washington State, USA). Fraction collector used 
was Spectra/Chrom CF1 (Spectrum 
Chromatography, Houston, USA) , Oven of 
Memmert (Memmert GmbH Germany), weighing 
balance (Shimadzu Corporation, Kyoto, Japan), 
Vortex mixer (Stuart, UK) and Melting points 
were determined in glass capillary tubes using 
Gallenkamp melting point apparatus 
(Bidspotter.Co.Uk). 
  
Extraction and isolation of compounds (A-I) 
 
For the purpose of effective extraction, whole 
plant material was shade-dried for 15 days. Then 
dried plant material was ground in blender and 
weighed. 
 
The extraction of this finely ground material was 
affected by simple maceration. An amount (800 
g) was taken in an extraction bottle and 
measured volume of dichloromethane (1500 ml) 
was added to it. Ultrasonication of this mixture 
was carried out occasionally in order to achieve 
maximum possible extraction. Filtration was 
carried out after 24 h of addition of solvent. The 
process was repeated three times with 
dichloromethane. The extraction of the plant 
material was done by methanol in the same 
manner. The dichloromethane and methanol 
extracts were concentrated separately under 
reduced pressure using a rotary evaporator. After 
the extraction process, 20.2 g of 
dichloromethane and 48.9 g of methanol extracts 
were obtained. The extracts were collected in 
separate sample bottles and designated CBWPD 
and CBWPM, respectively.  
 
Isolation of compound from dichloromethane 
extract 
 
Dichloromethane extract (18 g) was subjected to 
column chromatography on silica gel using 
stepwise elution with n-hexane-ethyl acetate 
((80:20 →70:30 → 60:40 → 50:50 
→ethylacetate) in increasing order of polarity. six 
fractions (CBWPD 1- CBWPD 6) were obtained. 
The fraction CBWPD 2 (4.07g) subjected to 
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column chromatography on silica gel using n-
hexane-ethylacetate (80:20 →70:30) as eluent 
resulted two fractions (2a and 2b). The fraction 
2a (1400 mg) was subjected to column 
chromatography on silica gel using n-hexane-
ethylacetate (60:40) as eluent which gave two 
pure compounds A (11 mg) and B (9 mg). The 
fraction CBWPD-3 (3.10g) was subjected to 
column chromatography on silica gel using n-
hexane-ethylacetate (80:20 →70:30) as eluent 
resulted two fractions (3a and 3b). The fraction 
3a (1200 mg) was subjected to column 
chromatography on silica gel using n-hexane-
ethylacetate (60:40) as eluent which gave two 
pure compounds C (12 mg) and D (14 mg).The 
fraction CBWPD-4 (2.74g) obtained by n-hexane-
ethyl acetate (80:20 →70:30) was subjected to 
column chromatography on silica gel using n-
hexane – EtOAc (60:40) as eluent  resulted two 
fractions (4a and 4b). The fraction 4a (850 mg) 
was subjected to column chromatography on 
silica gel using n-hexane – EtOAc (60:40) as 
eluent which gave two pure compounds E (8 mg) 
and F (6 mg). The fraction CBWPD-5 (1.0g) was 
subjected to column chromatography on silica 
gel using ethylacetate-methanol (80:20 →70:30) 
as eluent resulted two fractions (5a and 5b). The 
fraction 5a (500 mg) was subjected to column 
chromatography on silica gel hexane – EtOAc 
(60:40) as eluent which gave two pure 
compounds G (7 mg) and H (6 mg). Fraction 5b 
(50 mg) was subjected to column 
chromatography on Sephadex LH-20 using 
methanol as eluent afforded compound I (9 mg). 
The structures of these isolated compounds were 
established by spectroscopic technique such as 
UV and IR spectroscopy. Proton Nuclear 
Magnetic Resonance (1H NMR), 13C NMR and 
Mass spectrophotometry (EIMS, HRMS) were 
used for elucidation of structure. Isolation 
scheme of compounds (A-I) from 
dichloromethane extract of whole plant of croton 
bonplandianum (CBWPD) is given in Figure 1. 
 
 
Figure 1: Isolation scheme of compounds (A-I). Croton bonplandianum whole plant dichloromethane (CBWPD), 
Column chromatography (CC). * indicates the fraction having α-glucosidase inhibitory activity 
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In vitro α-glucosidase inhibition assay 
 
The α-glucosidase inhibitory activity was 
assessed by a standard method [6], with slight 
modifications. A volume of 60 μl of sample 
solution and 50 μL of 0.1 M phosphate buffer (pH 
6.8) containing α-glucosidase solution (0.2 U/mL) 
was incubated in 96 well plates at 37 ºC for 20 
min. After pre-incubation, 50 μL of 5 mM p-
nitrophenyl-α-D-glucopyranoside (PNPG) 
solution in 0.1 M phosphate buffer (pH 6.8) was 
added to each well and incubated at 37 ºC for 
another 20 min. The reaction was stopped by 
adding 160 μl of 0.2 M NaCO3 to each well, and 
absorbance readings were recorded at 405 nm 
by micro-plate reader and compared to control 
which had 60 μL of buffer solution in place of the 
extract. For blank incubation (to allow for 
absorbance produced by the extract), enzyme 
solution was replaced by buffer solution and 
absorbance recorded.  
 
The concentrations of test compounds which 
inhibited the hydrolysis of substrates by 50 % 
(IC50) were determined by monitoring the effect 
of decreasing concentrations of these extracts in 
the assays on the inhibition values. IC50 values 
were then calculated using EZ-Fit Enzyme 





All data were analyzed by analysis of variance 
(ANOVA) and mean values were compared by 
Duncan’s Multiple Range Tests using SPSS 
software, version 15 (SPSS Inc, Chicago, IL, 





Isolation of compound (A-I) 
 
Dichloromethane extract was subjected to a 
series of column and flash chromatographic 
techniques as described in the experimental to 
obtain nine compounds reported for the first time 
from this species. These are identified as of n-
pentacosanyl-n-nonadeca-7′-en-9′-α-ol-1′-oate 
(A), n-tridecanyl n-octadec-9,12-dienoate (B), 
nonacosyl hexadecanoate (C), heptacosanoic 
acid (D), 1,3,5-trihydroxy-2-hexadecanoylamino-
(6e,9e)-heptacosdiene (E), cumarin (F), betulin 
(G), stigmasterol (H), and 3,5-dimethoxy 4-
hydroxy cinnamic  acid (I) respectively, on the 
basis of their spectral data, structure  of isolated 





White amphorous powder (11 mg),  m.p.158–159 
°C; UV λmax MeOHnm (log ε): 224 (5.6) nm; IR 
(KBr) max cm-1:3487, 1751, 1618, 752 and 715 
cm-1; 1H-NMR (CDCl3, 400 MHz) δ:; 5.31 (1 H, 
dd, J = 18.6, 5.2 Hz), 5.28 (1 H, brs), 4.21 (1 H, J 
= 11.1 Hz), 4.17 (1 H, J = 11.1 Hz) 3.87 (1 H, 
br’m), 2.75 (2 H, brs), 2.32 (1 H, d, J = 6 Hz), 
1.65 (2 H, br’s), 1.23 – 1.28 (68 H, br’s), 0.88, 
0.91 (6 H, brs, 2 CH3); 13C-NMR (100 MHz 
CDCl3) δ; 167.7, 130.2, 128.1, 75.8, 68.2, 62.1, 
38.6, 32.1, 31.9 – 29.9, 24.7, 23.7, 23.1, 22.7, 
14.2 and 14.1; EI-MS; 662 (18.2);HR-EI-MS 
m/z:662.3329 C44H86O3 (calculated. for C44H86O3; 
662.3356);The physical and spectral data 
showed complete agreement with those reported 
in the literature [7].  
 
 n-Tridecanyl n-octadec-9,12-dienoate (B) 
 
Amorphous solid (12 mg); m.p. 91-92 °C; IR; 
1751 and 1648 cm-1 ;1H-NMR (CDCl3, 400 
MHz)δ: 0.83 and 0.90 (t, each, 6H, J = 7.1 Hz), 
1.23 – 1.27 (38 H, br’s), 2.42 (1H, d),  2.23 (1 H, 
d), 4.39 (2 H, triplet, J =7.5 Hz), δ 4.1 (2 H, 
triplet, J = 7.0 Hz),  5.23 (1H, dd, J = 14.9, 7.8 
Hz);  5.21 (1H, dt, J = 14.9, 7.8 Hz);  5.18 (1H, 
dt, J = 15.1, 7.1 Hz); 5.05 (1H, dt, J = 15.1, 7.1 
Hz); 13C-NMR (100 MHz CDCl3) δ:171.2, 135.6, 
130.8, 128.9, 126.9, 68.1, 49.6, 38.7, 33.6, 31.9, 
30.3 – 29.3, 28.6, 26.9, 24.1, 23.8, 22.9, 22.6, 
10.9 and 18.5; EI-MS; 462 (12), 460 (14), 421 
(27), 407 (19), 394 (13), 365 (15), 337 (11), 316 
(29), 295 (20), 297 (45), 253 (17), 197 (27), 167 
(79), 149 (89), 124 (100), 113 (55), 97 (51), 85 
(65), 71 (83), 57 (98) and 43 (80); HR-EI-
MSm/z:462.6685 C31H58O2 (calculated. For 
C31H58O2, 462.6689). The physical and spectral 




Colorless amorphous solid (11 mg); m.p. 105-
106 °C; IR;1652, 1615 and 1538 cm-1; 1H-
NMR(CDCl3, 400 MHz) δ:0.87, 0.94 (6H, triplet, J 
= 6.8 Hz),  1.25 – 1.38 (76H, br’s), 1.69 
(quintet), 2.03 (triplet, J = 7.2 Hz),  4.21 (1H, d, 
J = 8.7 Hz); 13C-NMR (100 MHz CDCl3) δ:169.3, 
69.1, 40.1, 33.0, 31.6 – 30.1, 24.9, 24.0, 11.4 
and 14.4; EI-MS; 662 (25), 647 (55), 592 (21), 
536 (18), 478 (23), 424 (19), 328 (21), 316 (15), 
280 (20), 197 (21), 191 (17), 167 (26), 149 (78), 
111 (19), 98 (33), 84 (43), 82 (41), 74 (65), 60 
(78), 44 (95) and 42 (100); HR-EI-
MSm/z:662.3479 (calculated. for C45H90O2; 
662.3477). The physical and spectral data 
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showed complete resemblance with the reported 
in the literature [9]. 
 
Heptacosanoic acid (D) 
 
Amorphous solid; m.p. 86-87 °C; IR (KBr) max 
cm-1:3322, 2688 and 1721; 1H-NMR (CDCl3, 400 
MHz) δ:0.91 (3H, triplet, J = 6.5 Hz), 1.59-1.61 
(48H, br’s), 1.98 (2 H, quintet), 2.11 (2H, triplet, 
J= 7.3 Hz);13C-NMR (100 MHz CDCl3) δ : 176.1 
(C-1), 34.9 (C-2), 32.1 (C-3), 29.6-29.9 (C-4-24), 
25.6 (C-25), 22.9 (C-26), 14.2 (C-27); EI-MS m/z 
(rel. int.): 410 (21), 367 (23), 341 (35), 320 (19), 
306 (13), 273 (17), 253 (18), 239 (17), 205 (19), 
192 (22), 169 (32), 149 (44), 137 (54) 111 (61), 
97 (78), 81 (82), 69 (100), 57 (88) and 41 (78); 
HR-EI-MSm/z:410.3782 (calcd. for C27H54O2, 
410.3765). The physical and spectral data 
corresponded to the reported values [10]. 
 
 
Figure 2: Structures of isolated compounds 
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Gummy solid (16 mg); []D25: – 26.2 (c 0.10, 
pyridine); IR (KBr):3340, 3220, 1660, 1620 and 
1540 cm-1 ; 1H-NMR (CDCl3, 400 MHz) δ: 0.89, 
0.94 (6H, triplet, J = 6.8 Hz), 1.28 (18H, br s), 
1.32 (18H, br s), 2.03 (2H, t, J = 7.0 Hz, H-4), 
2.15 (2H, t, J = 7.0 Hz, H-2’), 3.41 (2H, m, H-8), 
3.59 (1H, m, H-3), 3.65 (1H, dd, J= 11.5, 5.0 Hz, 
H-1b), 3.94 (1H, m, H-5), 4.22 (1H, dd, J= 11.3, 
4.9 Hz, H-1a), 4.87 (1H, dd, J = 15.5, 8.4 Hz);  
4.91 (1H, dt, J = 15.5, 8.4 Hz);  5.05 (1H, dt, J = 
16.1, 6.9 Hz); 5.18 (1H, dt, J = 16.1, 6.9 Hz); 13C-
NMR (100 MHz CDCl3) δ:169.4, 133.6, 132.4, 
130.7, 129.8, 82.4 (C-3), 74.7 (C-5), 69.1 (C-1), 
57.0 (C-2), 33.1 (C-4), 30.4 (C-8), 31.6, 30.8, 
30.4, 24.9, 24.0, 23.7, 21.6,  14.4, 11.4; EI-
MS:m/z (rel. int. %) 663 (12), 438 (32), 423 (28), 
379 (42), 335 (39), 305 (21), 292 (33), 279 (19), 
225 (62); HR-FAB-MS (+ive): m/z 664.6246 
(calculated. for C42H82NO4; 664.6249). The 
physical and spectral data showed complete 
agreement to the reported values [11]. 
 
2 H-1-Benzopyran-2-one (F) 
 
Colourless crystalline solid (11 mg); m.p. 70 oC; 
UV λmax MeOHnm (log ε): 298 (4.01), 238 (3.31), 
225 (2.99); IR (KBr) max cm-1: 1725, 1623, 1589, 
1512; 1H-NMR (CDCl3, 400 MHz) δ:6.41 (1H, d, 
J= 9.5 Hz, H-3), 7.25 (1H, d, J= 8.7 Hz, H-5), 
7.49 (1H, d, J= 8.7 Hz, H-8), 7.52 (2H, m, H-6, H-
7), 7.68 (1H, d, J= 9.5 Hz, H-4); EI-MS m/z (rel. 
int.): 146.0 (29); HR-EI-MS m/z:146.0534 (calcd. 
for C9H6O2,146.0538).The physical and spectral 




Crystallized from MeOH (20 mg); m.p. 251-
252°C; [α]D25: + 20.4° (c 0.42, C5H5N); IR (KBr) 
max: 3435, 3070, 1635, 880 cm-1; 1H-NMR (400 
MHz; CDCl3) δ: 4.68 (2H, m, H-29), 3.75 (1H, dd, 
J = 10.7, 4.2 Hz, H-3), 3.81, 3.42 (1H each, d, J 
= 11.0 Hz, H-28), 1.68 (3H, br. s, CH3-30), 1.02 
(3H, s, CH3-26), 0.98 (3H, s, CH3-27), 0.92 (3H, 
s, CH3-24), 0.89 (3H, s, CH3-23), 0.87 (3H, s, 
CH3-25); EI-MS (rel. int. %) m/z: 442 [M]+  (15); 
HR-EI-MS m/z: 442.3814 (calculated for 
C30H50O2; 442.3818);The physical and spectral 




Colorless crystalline solid (17 mg); m.p. 170-171 
°C; [α]D25; -51.5˚ (c = 0.28, CHCl3); IR (CHCl3) 
max cm-1: 3432 (OH), 1648 (C = C); 1H-NMR 
(CDCl3, 400 MHz) δ: 5.33 (1H, m, H-6), 5.15 (1H, 
dd, J = 15.2, 8.4 Hz, H-22), 5.02 (1H, dd, J = 
15.2, 8.6 Hz, H-23), 3.28 (1H, m, H-3), 0.90 (3H, 
d, J = 6.5 Hz, Me-21), 0.83 (3H, d, J = 6.6 Hz, 
Me-26), 0.84 (3H, t, J = 7.0 Hz, Me-29), 0.81 
(3H, d, J = 6.5 Hz, Me-27), 0.80 (3H, s, Me-19), 
0.65 (3H, s, Me-18); EIMS m/z (rel. int. %): [M]+ 
412 (8) HREIMS m/z: 412.3919 (calculated for 
C29H48O, 412.3930).The physical and spectral 
data showed complete resemblance with the 
those reported in the literature [14-15]. 
 
3,5-dimethoxy 4-hydroxy cinamic  acid (I) 
 
Yellow solid from acetone (15 mg); m.p. 89-90 
0C; UV λmax MeOH nm (log ε): 329 (4.01), 239 
(3.92), 205 (3.85) nm; IR (KBr)υmax cm-1: 3363, 
1704, 1663, 1604, 1449 cm−1; 1H-NMR  (CDCl3, 
400 MHz):7.58 (1H, doublet, J =16 Hz), 6.88 ( 2 
H, singlet), 6.32 (1 H, doublet, J =  16 Hz) , 4.85 
(OH ) and 3.86 (6 H , singlet); 13C-NMR (CDCI3, 
100 MHz): 170.87, 149.47, 147.11, 139.51, 
126.74, 116.37, 106.85, 147.11, 116.36, 106.84 
and 56.85. EIMS m/z (rel. int) %:  224 (38), 196 
(36), 190 (45), 161 (34), 149 (45), 131 (12), 119 
(24), 107 (15) and 78 (49); HREIMS m/z M+ 
224.1233(calculated for C11H12O5; 224.1241). 
The physical and spectral data corresponded to 
the reported values [16]. 
 
In vitro α-glucosidase inhibition  
 
All the isolated compounds were screened for α-
glucosidase inhibitory activity. Compound  2H-1-
Benzopyran-2-one (F), Betulin (G) & 3, 5-
Dimethoxy 4-hydroxy cinnamic acid (I) 
possessed significant α-glucosidase inhibitory 
activity in a concentration-dependent manner, 
and showed more potent inhibitory activity, with 
IC50 values ranging from 23.0 to 26.7 μM, than 
that of a positive control acarbose (IC50, 38.2 




Diabetes is one of the world's greatest health 
problems, affecting about 171 million people and 
most of these will be dominated by those 
suffering from type II diabetes [17]. One of the 
strategies to monitor blood glucose for type II 
diabetes mellitus is to either inhibit or reduce the 
production of glucose from the small intestine. 
Diet rich in carbohydrate causes sharp rise in the 
blood glucose level as the complex 
carbohydrates in the food is rapidly absorbed in 
the intestine aided by the α-glucosidase enzyme 
which breaks disaccharides into absorbable 
monosaccharides, 
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Table 1: α-Glucosidase inhibition (mean ± SEM, n = 3) of compounds (A-I) isolated from dichloromethane 
extracts of Croton bonplandianum, a = positive control 
 
Compound Inhibition (%) IC50 
(μg/mL) 160(μg/mL)  80 (μg/mL ) 40 (μg/mL ) 20 (μg/mL)  10 (μg/mL)  
A 286 316 346 395 435 >250 
B 294 334 377 399 419 >250 
C 59.8 ± 1.2 21.2 ± 2.2 9.8 ± 1.4 3.2 ± 1.7 – 214.5 
D 81.7 ± 2.4 50.5 ± 1.6 31.0 ± 1.1 6.1 ± 1.2 – 94.7 
E – – – – – >250 
F 92.5 ± 2.6 87.8 ± 1.4 70.4 ± 2.0 53.2 ± 1.8 28.4± 1.2 25.9 
G 95.2 ± 4.2 89.9 ± 3.2 72.9 ± 1.4 51.0 ± 1.4 27.3 ± 1.4 23.0 
H 96.4 ± 2.5 65.2 ± 1.9 38.2 ± 1.4 4.5 ± 1.2 – – 72.8 
I 92.1 ± 5.6 77.5 ± 1.7 65.4 ± 1.2 46.5 ± 1.3 29.7 ± 2.0 26.7 
Acarbosea 92.23±0.14 81.39±0.23 71.09±0.56 57.42±0.44 48.02±0.24 38.25 
 
α-glucosidase inhibitor inhibits the disaccharide 
digestion and impedes the postprandial glucose 
excursion to enable overall smooth glucose 
profile [18]. Thus, natural products of great 
structural diversity are still a good source for 
searching for such inhibitors, thereby motivating 
to explore biologically active compounds from the 
highly diverse plants. 
  
The development of the alpha-glucosidase 
inhibitor provides a new approach in the 
management of diabetes. By competitive and 
reversible inhibition of intestinal alpha-
glucosidases, alpha-glucosidase delays 
carbohydrate digestion, prolongs the overall 
carbohydrate digestion time, and thus reduces 
the rate of glucose absorption. After oral 
administration of alpha-glucosidase, the 
postprandial rise in blood glucose is dose-
dependently decreased, and glucose-induced 
insulin secretion is attenuated. Due to diminished 
postprandial hyperglycemia and hyper-
insulinemia by alpha-glucosidase inhibitor, 
triglyceride uptake into adipose tissue, hepatic 
lipogenesis, and triglyceride content are reduced. 
Therefore, alpha-glucosidase inhibitor treatment 
not only flattens postprandial glycemia, due to 
the primary and secondary pharmacodynamic 
effects, but also ameliorates the metabolic state 
in general.  
 
Thus, alpha-glucosidase inhibitor may have the 
potential to delay or possibly prevent the 
development of diabetic complications [19]. 
Compound  2H-1-Benzopyran-2-one (F), Betulin 
(G) & 3, 5-Dimethoxy 4-hydroxy cinnamic acid (I) 
possessed significant α-glucosidase inhibitory 
activity in a concentration-dependent manner, 
and showed more potent inhibitory activity, with 
IC50 values ranging from 23.0 to 26.7 μM, than 
that of a positive control acarbose (IC50, 38.2 
μM). It has been displayed that these 
compounds are attractive candidates for α-




In the light of these findings, the isolated 
compounds exhibited inhibitory activity against α-
glucosidase in a dose-dependent manner and 
therefore may potentially be developed as new 
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